Bluebird Bio Sells to Private Equity After Financial Struggles Business By Jack Mulligan Bluebird Bio announced on Friday that it will sell itself to private equity firms Carlyle and SK Capital for about…
Vertex Pharmaceuticals: A Robust Healthcare Investment Opportunity Economy By Lorenzo Sorvani Vertex Pharmaceuticals (VRTX) stands as a shining star in the healthcare sector, primarily owing to its remarkable strides in cystic…
Regeneron Pharmaceuticals: A Promising Future Ahead Business By Lorenzo Sorvani Regeneron Pharmaceuticals (REGN 0.68%) has been making waves in the biotech industry, with a remarkable growth trajectory and a solid…
